past
decad
asia
activ
engag
human
genom
studi
made
great
contribut
field
increas
number
genom
institut
consortium
initi
across
contin
studi
associ
genet
variat
diseas
despit
laudabl
effort
asia
face
tremend
challeng
term
fund
regul
collabor
ethic
legal
social
issu
relat
genom
need
address
near
futur
promot
develop
genom
medicin
past
decad
seen
advanc
human
genet
genom
worldwid
variou
countri
invest
serious
field
expect
gain
better
understand
human
health
diseas
biobank
genet
databas
built
facilit
interdisciplinari
clinic
research
region
intern
effort
also
made
promot
success
genom
medicin
exampl
europ
biobank
biomolecular
resourc
research
infrastructur
construct
secur
global
competit
research
industri
european
union
benefit
health
european
citizen
intern
genom
research
collabor
human
genom
project
hgp
intern
hapmap
project
intern
cancer
genom
consortium
produc
openaccess
genet
databas
research
around
globe
kay
vaught
et
al
complet
sequenc
human
genom
mathemat
analysi
dna
variant
call
singl
nucleotid
polymorph
snp
progress
genomewid
associ
studi
contribut
dramat
biomed
research
yet
major
medic
genom
research
mainli
focus
peopl
european
descent
result
benefici
greatest
segment
world
popul
given
lack
divers
studi
bia
understand
associ
genet
variant
diseas
research
recogn
import
inclus
popul
divers
pharmacogenom
genomewid
diseas
studi
bustamant
et
al
geopolit
contin
asia
contain
almost
twothird
world
popul
rich
cultur
ethnic
linguist
genet
divers
asian
nation
particularli
still
develop
often
depict
epicent
pandem
eg
sever
acut
respiratori
syndrom
sar
avian
influenza
outbreak
tan
et
al
time
countri
also
face
grow
chronic
diseas
burden
caus
diseas
asian
popul
remain
unknown
jemal
et
al
thu
genom
research
asian
popul
essenti
enhanc
knowledg
genet
basi
complex
chronic
infecti
diseas
cope
asian
global
public
health
challeng
articl
first
give
brief
introduct
contribut
asian
nation
human
genom
place
greater
focu
genom
consortium
initi
region
asian
cohort
consortium
acc
human
genom
organ
hugo
panasia
snp
consortium
pasnp
hugo
panasia
popul
genom
initi
pasnp
discuss
challeng
asia
face
bring
genom
scienc
technolog
bear
applic
genom
medicin
final
outlin
sever
futur
perspect
advanc
genom
asia
world
largest
geopolit
contin
asia
exhibit
heterogen
geograph
cultur
socioeconom
characterist
invest
progress
genom
scienc
technolog
countri
across
contin
uneven
wealthi
countri
singapor
japan
made
tremend
invest
genom
research
develop
r
toward
effici
diagnosi
tool
person
medicin
genom
institut
singapor
gi
locat
singapor
biomed
hub
biopoli
one
center
excel
genom
asia
inde
world
gi
gain
world
recognit
rapid
respons
sar
identif
five
strain
sar
coronaviru
effect
contain
pandem
strength
gi
research
lie
three
mileston
arena
infecti
diseas
crossnat
scienc
diplomaci
regen
medicin
fischer
japan
establish
sever
research
institut
eg
riken
center
genom
medicin
research
infrastructur
eg
biobank
japan
steer
nation
ahead
path
toward
genom
applic
medicin
health
yoshizawa
et
al
emerg
economi
china
india
rise
power
global
biomedicin
field
challeng
develop
economi
salter
faulkner
china
sole
develop
countri
particip
hgp
contribut
toward
sequenc
human
genom
beij
genom
institut
bgi
becom
global
sequenc
powerhous
sequenc
first
asian
human
genom
number
plant
anim
genom
rice
silkworm
chicken
panda
normil
india
endeavor
foster
econom
develop
address
local
health
need
invest
genomicsbas
innov
indian
genom
variat
consortium
governmentfund
collabor
network
sever
local
institut
one
exampl
reflect
effort
hardi
et
al
still
asian
countri
indonesia
philippin
emerg
recent
year
activ
actor
field
genom
partli
due
ethnic
linguist
divers
liu
effort
nation
across
contin
crucial
asia
genom
research
collabor
network
acc
apsnp
introduc
network
detail
first
propos
novemb
seoul
acc
collabor
cancer
cohort
research
project
involv
one
million
healthi
peopl
across
asia
follow
time
variou
diseas
endpoint
reach
acc
seek
understand
relationship
genet
environment
exposur
etiolog
diseas
discov
earli
detect
biomark
acc
two
mission
serv
platform
crosscohort
collabor
project
combin
analysi
ii
act
incub
new
cohort
song
et
al
acc
approxim
activ
member
bangladesh
china
india
iran
japan
south
korea
malaysia
singapor
taiwan
unit
state
among
other
cochair
john
potter
fred
hutchinson
cancer
research
center
seattl
washington
usa
daehe
kang
seoul
nation
univers
colleg
medicin
south
korea
coordin
center
locat
fred
hutchinson
cancer
research
center
provid
support
scientif
collabor
coordin
commun
data
oper
statist
consult
rolland
et
al
studi
associ
bodi
mass
index
bmi
risk
death
conduct
north
american
european
popul
less
known
associ
asian
popul
focu
acc
project
bmi
asian
popul
date
crosscohort
collabor
project
acc
yield
seven
articl
show
associ
bmi
risk
death
bmi
diabet
bmi
tobacco
smoke
alcohol
consumpt
risk
cancer
small
intestin
bmi
risk
death
pancreat
cancer
meat
consumpt
causespecif
mortal
bmi
cardiovascular
diseas
mortal
asian
popul
http
wwwasiacohortorg
indexhtml
access
snp
consortium
establish
earli
collabor
effort
among
major
pharmaceut
compani
wellcom
trust
five
lead
academ
center
provid
resourc
pool
clinic
genom
research
discoveri
novel
diagnosi
person
therapi
holden
consortium
larg
focus
caucasian
popul
genom
variat
among
asian
peopl
remain
unexplor
hugo
panasia
snp
consortium
pasnp
set
research
institut
asian
countri
map
human
genet
divers
asia
coordin
gi
pasnp
took
first
step
toward
collabor
among
asian
scientist
base
strong
bioinformat
team
china
india
japan
singapor
etc
divers
ethnic
indonesia
malaysia
philippin
taiwan
scientist
common
interest
consortium
use
sampl
individu
repres
popul
conduct
migrat
studi
normil
normil
pasnp
consortium
first
report
publish
scienc
decemb
provid
physic
map
human
variat
southeast
asian
east
asian
ea
central
south
asian
popul
show
strong
evid
southern
migrat
rout
asia
though
complet
rule
twowav
model
migrat
abdulla
et
al
order
advanc
work
pasnp
hugo
panasia
popul
genom
initi
launch
version
pasnp
establish
larger
network
hundr
research
construct
gene
pool
divers
peopl
data
cultur
includ
mainland
central
asia
pacif
island
goal
pasnp
explor
asian
migrat
pattern
asian
genet
divers
local
adapt
eventu
translat
genom
knowledg
practic
genom
medicin
data
collect
pasnp
open
worldwid
scientif
commun
genom
studi
http
papgiorgindexphpaboutu
access
despit
achiev
asian
countri
consortium
made
still
face
formid
challeng
term
fund
regul
collabor
ethic
legal
social
issu
elsi
genom
asia
show
next
section
develop
human
genom
asia
face
similar
issu
nation
transnat
endeavor
fund
standard
data
sampl
harmon
elsi
practic
regul
gain
public
trust
also
asiaspecif
issu
local
concern
practic
asian
scienc
collabor
fund
fund
genom
scienc
becom
competit
difficult
obtain
govern
industri
sourc
reason
ensur
sustain
fund
one
major
challeng
genom
studi
vaught
et
al
even
singapor
govern
attract
mani
top
scientist
west
substanti
fund
two
period
multibillion
dollar
invest
littl
warn
core
budget
bioscienc
institut
agenc
scienc
technolog
research
star
cut
thirdyear
period
begin
star
bioscientist
includ
gi
compet
grant
new
industri
align
fund
collabor
clinician
industri
clinic
applic
fischer
normil
elsewher
bgi
took
entrepreneuri
approach
fuel
growth
sequenc
bioinformat
capabl
borrow
billion
us
dollar
governmentown
bank
must
begin
pay
back
princip
within
year
sinc
sequenc
make
money
bgi
establish
subsidiari
compani
expand
applic
genom
scienc
technolog
order
pay
debt
gener
incom
normil
exampl
bgi
diagnost
offer
health
servic
noninvas
prenat
test
test
variou
genet
disord
bgi
ark
biotechnolog
co
ltd
set
transgen
platform
clone
platform
experiment
farm
anim
model
depart
see
bgi
websit
addit
challeng
fund
asian
countri
also
find
regul
problem
appoint
first
director
hgp
jame
watson
resolv
us
nation
institut
health
alloc
part
fund
studi
elsi
genom
face
unpreced
challeng
pose
genom
futur
applic
research
elsi
genom
initi
first
usa
thenc
spread
canada
europ
zwart
neli
awar
issu
east
happen
much
later
research
suppos
studi
similar
issu
west
purpos
outcom
lead
better
regul
genom
recent
yoshizawa
et
al
identifi
heterogen
regulatori
framework
elsi
practic
among
ea
countri
found
ea
countri
regul
genom
rel
inconsist
mix
charact
consid
aspect
privaci
exampl
japan
singapor
south
korea
taiwan
regul
oversight
protect
person
inform
china
indonesia
exert
littl
control
privaci
issu
similar
situat
seen
ethic
review
even
though
ethic
review
committe
nearli
countri
discrep
ethic
review
capac
implement
oversight
differ
countri
notic
yoshizawa
et
al
perhap
greater
concern
overal
term
limit
even
absent
regul
mani
develop
countri
countri
may
limit
capac
regul
innov
genom
medicin
could
major
barrier
applic
emerg
genom
medicin
product
improv
global
health
therefor
signific
includ
develop
countri
intern
confer
harmon
well
intern
consortia
develop
countri
help
improv
regulatori
capac
develop
countri
hardi
et
al
yet
intern
health
research
collabor
develop
develop
countri
field
human
genet
often
sensit
issu
concern
possibl
exploit
popul
develop
countri
commerci
human
tissu
unfair
benefit
share
ownership
develop
develop
countri
schulzbald
et
al
biodiversityrich
countri
like
china
india
indonesia
concern
exploit
genet
resourc
develop
countri
uneasi
equit
benefit
share
ownership
intellectu
properti
right
intern
research
collabor
consequ
china
promulg
interim
measur
administr
human
genet
resourc
issu
ministri
scienc
technolog
ministri
health
direct
stipul
collabor
chines
parti
foreign
research
get
access
chines
genet
resourc
chen
fear
indonesia
may
benefit
vaccin
develop
intern
scientist
multin
pharmaceut
compani
indonesian
govern
stop
send
viru
specimen
world
health
organ
stanc
support
malaysia
thailand
develop
countri
commun
desir
mutual
trust
transpar
equiti
develop
develop
nation
viru
share
mechan
moreov
indonesia
revis
health
law
enact
ministri
health
regul
materi
transfer
agreement
order
safeguard
nation
sovereignti
biolog
materi
sedyaningsih
et
al
although
india
ethic
guidelin
regul
place
prevent
biopiraci
lack
adher
regul
absenc
strict
implement
measur
monitor
misus
genet
sampl
kumar
china
face
similar
problem
protect
use
chines
genet
resourc
research
collabor
offic
legisl
affair
state
council
peopl
republ
china
publish
exposur
draft
measur
administr
human
genet
resourc
onlin
solicit
advic
public
write
offici
measur
still
issu
http
access
biopiraci
issu
reflect
complex
crossbord
collabor
well
import
mutual
trust
equiti
among
scientist
use
human
genet
although
potenti
danger
biopiraci
unfair
benefit
share
collabor
develop
countri
develop
countri
northsouth
collabor
collabor
nevertheless
promot
strategi
help
build
develop
nation
research
translat
capac
schulzbald
et
al
increasingli
also
trend
toward
collabor
among
develop
countri
southsouth
collabor
build
human
resourc
capac
iver
et
al
case
pasnp
consortium
edison
liu
one
key
organ
consortium
found
challeng
coordin
scienc
collabor
among
asian
scientist
point
scientist
asia
tendenc
look
past
focu
collabor
unit
state
europ
partli
collabor
get
credit
school
administr
also
asia
countri
see
competitor
get
peopl
togeth
accomplish
liu
scienc
cultur
asia
differ
among
scientist
west
tend
hierarch
bureaucrat
anoth
challeng
rest
dispar
research
capac
research
infrastructur
asian
countri
liu
besid
challeng
asian
genom
research
collabor
face
similar
challeng
intern
scienc
commun
gener
largescal
genom
research
collabor
requir
data
comparison
valid
across
differ
popul
lack
harmon
elsi
lack
regulatori
infrastructur
genom
research
applic
major
hurdl
also
difficult
crucial
ensur
qualiti
sampl
interoper
data
collabor
song
et
al
vaught
et
al
final
translat
genom
knowledg
genom
medicin
innov
medicin
product
necessit
interact
collabor
stakehold
scientist
clinician
policymak
industri
peopl
also
patient
consum
healthi
individu
engag
public
biobank
genom
studi
great
import
research
need
access
patient
public
biolog
sampl
good
number
qualit
quantit
studi
public
percept
biobank
genet
databas
western
countri
explor
public
reason
particip
particip
biobank
studi
view
issu
inform
consent
benefit
share
commerci
internation
concern
privaci
discrimin
ownership
return
result
howev
except
limit
studi
asian
countri
among
china
japan
singapor
littl
known
asian
public
percept
biobank
investig
public
percept
biobank
reveal
sever
factor
affect
public
willing
donat
sampl
research
particip
studi
factor
includ
public
understand
biobank
trust
research
institut
scientist
run
institut
consider
privaci
discrimin
commerci
asia
tendenc
public
distrust
scienc
exampl
singapor
grow
emphasi
commerci
scienc
discourag
public
particip
research
japan
public
trust
expertis
erod
follow
earthquak
tsunami
nuclear
accid
arimoto
sato
case
report
public
distrust
expert
public
concern
misus
genet
inform
genet
discrimin
genet
test
china
south
korea
taiwan
tension
distrust
aros
public
author
taiwan
biobank
due
lack
open
scienc
commun
yoshizawa
et
al
wellknown
case
scientif
fraud
south
korea
bonetta
japan
tsurimoto
et
al
china
lin
also
contribut
lack
trust
public
scientist
signal
call
interfac
scienc
societi
activ
interact
public
result
rich
divers
genet
resourc
togeth
polit
variou
countri
great
effort
scientist
made
asia
rise
field
human
genom
postgenom
era
build
region
collabor
genom
network
acc
pasnp
first
vital
step
toward
better
scienc
medicin
health
asia
research
conduct
network
competit
global
arena
bridg
gap
asia
western
countri
howev
compar
research
collabor
europ
north
america
asian
genom
network
face
challeng
counterpart
west
emerg
economi
develop
countri
asia
establish
consist
robust
regulatori
framework
govern
conduct
genom
research
furthermor
elsi
practic
regul
often
influenc
local
sociopolit
cultur
concern
tend
heterogen
disincent
region
collabor
genom
scienc
technolog
requir
harmon
elsi
practic
regul
across
asia
therefor
futur
help
place
emphasi
research
elsi
genom
develop
regulatori
infrastructur
could
becom
tool
secur
public
trust
scienc
also
import
encourag
northsouth
collabor
southsouth
collabor
experi
gain
pasnp
could
contribut
collabor
basi
previou
network
research
collabor
editor
note
